JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB227679

Anti-CD276 抗体 [SP265] - C-terminal

Anti-CD276 antibody [SP265] - C-terminal

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal CD276 antibody. C-terminal. Suitable for Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 2 publications.

別名を表示する

CD276, B7H3, PSEC0249, UNQ309/PRO352, CD276 antigen, 4Ig-B7-H3, B7 homolog 3, Costimulatory molecule, B7-H3

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-CD276 antibody [SP265] - C-terminal (AB227679)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CD276 antibody [SP265] - C-terminal (AB227679)

ab227679 staining CD276 in wild-type HEK293 cells (top panel) and CD276 knockout HEK293 cells (ab266658) (bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab227679 at 1/100 dilution and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Western blot - Anti-CD276 antibody [SP265] - C-terminal (AB227679)
  • WB

Supplier Data

Western blot - Anti-CD276 antibody [SP265] - C-terminal (AB227679)

All lanes:

Western blot - Anti-CD276 antibody [SP265] - C-terminal (ab227679) at 1/100 dilution

All lanes:

Hs 700T (human pancreatic adenocarcinoma cell line) cell lysate

Predicted band size: 57 kDa

true

Immunocytochemistry/ Immunofluorescence - Anti-CD276 antibody [SP265] - C-terminal (AB227679)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-CD276 antibody [SP265] - C-terminal (AB227679)

Immunocytochemistry/ Immunofluorescence analysis of LNCaP (Human prostate carcinoma epithelial cell) cells labeling CD276 with purified ab227679 at 1/25 (9.24 μg/ml). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Flow Cytometry - Anti-CD276 antibody [SP265] - C-terminal (AB227679)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CD276 antibody [SP265] - C-terminal (AB227679)

Flow cytometric analysis of PC-3 (human prostate adenocarcinoma cell line) cell line labeling CC276 with ab227679 at 1/400 (green) compared with a rabbit isotype control (blue).

関連する標識済み抗体及び組成の異なる製品 (10)

  • Carrier free

    Anti-CD276 antibody [SP265] - BSA and Azide free

  • 578 PE

    PE Anti-CD276 antibody [SP265] (C-terminal)

  • 660 APC

    APC Anti-CD276 antibody [SP265] (C-terminal)

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CD276 antibody [SP265] - C-terminal

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CD276 antibody [SP265] - C-terminal

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-CD276 antibody [SP265] - C-terminal

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CD276 antibody [SP265] - C-terminal

  • HRP

    HRP Anti-CD276 antibody [SP265] (C-terminal)

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CD276 antibody [SP265] - C-terminal

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-CD276 antibody [SP265] - C-terminal

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

SP265

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, ICC/IF, Flow Cyt

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/400", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/100", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/25 - 1/100", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }
style
left-column
style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A/G
精製に関する特記事項
Purified from TCS by protein A/G.
バッファー組成
pH: 7.6 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CD276 also known as B7-H3 is an immunoregulatory protein with a mass of approximately 57 kDa although post-translational modifications can increase its observed size. It is a member of the B7 family which is part of the immunoglobulin superfamily. CD276 is widely expressed in various tissues including placenta liver heart and also in many tumor cells. It is observed in lesser amounts in normal tissues making it an interesting target for cancer research. Various assays like HEK293 and HEK293T cell confluency studies often use CD276 to explore its expression under different conditions and seeding densities which are represented in confluency charts.
Biological function summary

CD276 modulates immune responses by acting as a co-inhibitory ligand impacting T-cell proliferation and cytokine synthesis. Not part of a known complex it plays a role in the adaptive immune system by providing negative feedback regulation that can inhibit the immune response. This capability has implications in preventing autoimmunity but may also contribute to tumor immune evasion by reducing effective anti-tumor responses. The B7-H3/CD276 interaction with receptors such as IL receptor family members suggests its diverse immunomodulatory functions.

Pathways

CD276 participates in the T-cell receptor (TCR) signaling pathways influencing immune checkpoint pathways. It interacts with other immune checkpoint proteins like PD-L1 and CTLA-4 but its exact receptor partner remains unidentified. The presence of CD276 in these pathways highlights its role in controlling T-cell activation and tolerance. By modulating TCR signals and impacting downstream effects CD276 serves as a regulatory point that can balance immune activation and inhibition critical in immune-mediated conditions.

CD276 has strong associations with cancer particularly in solid tumors such as prostate and breast cancer. It is often overexpressed in malignant tissues contributing to immune evasion by tumors. Researchers propose it as a potential target for cancer immunotherapy due to this attribute. CD276's link to disorders like asthma has also been suggested where its interaction with proteins involved in inflammatory pathways such as IL response elements can exacerbate the condition. This implicates it as a dual-role protein in both disease progression and potential therapeutic targeting.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling.
See full target information CD276
style
left-column

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in oncology 10:1527 PubMed32984002

2020

MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjian Li,Cheng Huang,Zongliang Zhang,Yunyu Feng,Zeng Wang,Xin Tang,Kunhong Zhong,Yating Hu,Gang Guo,Liangxue Zhou,Wenhao Guo,Jianguo Xu,Hui Yang,Aiping Tong

Theranostics 10:10498-10512 PubMed32929362

2020

Combination therapy with B7H3-redirected bispecific antibody and Sorafenib elicits enhanced synergistic antitumor efficacy.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng Huang,Hongjian Li,Yunyu Feng,Xiaoling Li,Zongliang Zhang,Caiying Jiang,Jichao Wang,Chenli Yang,Yuying Fu,Min Mu,Shasha Zhao,Zeng Wang,Yi Kuang,Huan Hou,Yuelong Wang,Wenhao Guo,Jianguo Xu,Hui Yang,Liangxue Zhou,Aiping Tong,Gang Guo
View all publications
style
left-column
style
left-column
style
right-column

Alternative Products

Primary Antibodies

AB218280

Alexa Fluor® 488 Anti-CD276 antibody [EPNCIR122]

RabMAb|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 488 Anti-CD276 antibody [EPNCIR122] (AB218280)

  • 0
  • 0
Primary Antibodies

AB218283

Alexa Fluor® 555 Anti-CD276 antibody [EPNCIR122]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 555 Anti-CD276 antibody [EPNCIR122] (AB218283)

  • 0
  • 0
Primary Antibodies

AB134161

Anti-CD276 antibody [EPNCIR122]

RabMAb|Recombinant|KO Validated|20ul selling size

Western blot - Anti-CD276 antibody [EPNCIR122] (AB134161)

  • 0
  • 0
Primary Antibodies

AB219648

Anti-CD276 antibody [EPR20115]

RabMAb|Recombinant|KO Validated|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

  • 4
  • 1
Primary Antibodies

AB256585

Anti-CD276 antibody [EPNCIR122] - BSA and Azide free

RabMAb|Recombinant|KO Validated

Flow Cytometry - Anti-CD276 antibody [EPNCIR122] - BSA and Azide free (AB256585)

  • 0
  • 0
Primary Antibodies

AB227670

Anti-CD276 antibody [SP206]

BOND RX™ Validated|RabMAb|Recombinant|KO Validated|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [SP206] (AB227670)

  • 5
  • 1
Primary Antibodies

AB227577

Anti-CD276 antibody [EPR20115] - BSA and Azide free

RabMAb|Recombinant|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] - BSA and Azide free (AB227577)

  • 0
  • 1
Primary Antibodies

AB209895

Anti-CD276 antibody [EPNCIR122] - Low endotoxin, Azide free

RabMAb|Recombinant|KO Validated

Flow Cytometry - Anti-CD276 antibody [EPNCIR122] - Low endotoxin, Azide free (AB209895)

  • 0
  • 0

Complementary Products

Assay Kits

AB221831

Human CD276 ELISA Kit

Recombinant

ELISA - Human CD276 ELISA Kit (AB221831)

  • 0
  • 0
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB205921

Anti-PD-L1 antibody [28-8]

BOND RX™ Validated|20ul selling size|Recombinant|KO Validated|Advanced Validation|RabMAb

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PD-L1 antibody [28-8] (AB205921)

  • 4
  • 15
Primary Antibodies

AB20034

Anti-FOXP3 antibody [236A/E7]

BOND RX™ Validated|Recombinant|Lab Essentials|Advanced Validation

Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)

  • 4
  • 38
Primary Antibodies

AB15580

Anti-Ki67 antibody

BOND RX™ Validated|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody (AB15580)

  • 5
  • 230

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com